145 related articles for article (PubMed ID: 25091195)
1. Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
Chang ML; Hsu CM; Tseng JH; Tsou YK; Chen SC; Shiau SS; Yeh CT; Chiu CT
J Gastroenterol Hepatol; 2015 Feb; 30(2):329-36. PubMed ID: 25091195
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
[TBL] [Abstract][Full Text] [Related]
3. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ; Wang PW; Hu TH
PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
[TBL] [Abstract][Full Text] [Related]
4. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
5. UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.
Labruna G; Pasanisi F; Nardelli C; Tarantino G; Vitale DF; Bracale R; Finelli C; Genua MP; Contaldo F; Sacchetti L
J Endocrinol Invest; 2009 Jun; 32(6):525-9. PubMed ID: 19474520
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence rate and risk factor analysis of nonalcoholic fatty liver disease in 115 female patients with schizophrenia].
Yu Y; Zhao J; Jin YL; Xie Q; Yao DF; Yao M
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):947-953. PubMed ID: 37872090
[No Abstract] [Full Text] [Related]
7. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.
Valle M; Martos R; Gascón F; Cañete R; Zafra MA; Morales R
Diabetes Metab; 2005 Feb; 31(1):55-62. PubMed ID: 15803114
[TBL] [Abstract][Full Text] [Related]
8. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
9. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.
Kanaya AM; Wassel Fyr C; Vittinghoff E; Harris TB; Park SW; Goodpaster BH; Tylavsky F; Cummings SR
Arch Intern Med; 2006 Feb; 166(3):350-6. PubMed ID: 16476877
[TBL] [Abstract][Full Text] [Related]
11. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
12. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
[TBL] [Abstract][Full Text] [Related]
13. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis.
Shih PH; Shiue SJ; Chen CN; Cheng SW; Lin HY; Wu LW; Wu MS
Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33809062
[TBL] [Abstract][Full Text] [Related]
15. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease.
Ke F; Xue G; Jiang X; Li F; Lai X; Zhang M; Shen Y; Gao L
Cytokine; 2020 Oct; 134():155184. PubMed ID: 32645536
[TBL] [Abstract][Full Text] [Related]
16. Fatty liver index is associated with the risk of testosterone deficiency in aging men without metabolic syndrome.
Liu CC; Huang SP; Hsieh TJ; Lee CH; Cheng KH; Huang TY; Geng JH; Li CC; Wu WJ; Lee YC
Andrology; 2021 May; 9(3):863-872. PubMed ID: 33484089
[TBL] [Abstract][Full Text] [Related]
17. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
[TBL] [Abstract][Full Text] [Related]
18. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Alsharoh H; Ismaiel A; Leucuta DC; Popa SL; Dumitrascu DL
J Gastrointestin Liver Dis; 2022 Jun; 31(2):206-214. PubMed ID: 35574617
[TBL] [Abstract][Full Text] [Related]
20. Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.
Nazal L; Riquelme A; Solís N; Pizarro M; Escalona A; Burotto M; Méndez JI; Saint-Jean C; Concha MJ; Giovanni S; Awruch D; Morales A; Baudrand R; Carrasco G; Domínguez MA; Padilla O; Espinoza M; Miquel JF; Nervi F; Arrese M
Obes Surg; 2010 Oct; 20(10):1400-7. PubMed ID: 20066503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
